Advances
in Biopharmaceutical Technology in China
A Society for Industrial Microbiology and BioPlan Associates co-publication
Every organization has a China strategy, though for many of us it is
simply “ignore it.” A great opportunity exists in working
with China and implementing an effective company strategy. However,
winning in Asia in the new millennium will require fundamental changes
in partnerships between western and Asian companies. Every company
faces the question “What should our China strategy be?” But
to neglect China is to forego opportunities to gain efficiency in most
of the things we are trying to do. China provides opportunities
that allow us to do different things and not just do things differently.
This volume provides an overview of the biopharmaceutical industry,
and the state of technology. It will help the reader understand general
business practice in China, analyze business opportunities and in identifying
potential partners for working in China. It provides a ready reference
for all aspects of the world of biopharmaceuticals in China, including
general understanding, detailed technical and business descriptions, and
detailed information on all types of organizations involved in biopharmaceuticals
in China, whether they be companies (state owned or privately owned), universities,
or government institutions.
Download
PDF Brochure [PDF
216k]
Free! Purchasers of Advances in Biopharmaceutical
Technology in China also receive a 1-year License to the China
Biotherapeutics Database, the only comprehensive English listing
of biopharmaceutical products marketed in China.
|
